Medtronic Plc [NYSE: MDT] gained 1.40% or 1.12 points to close at $80.86 with a heavy trading volume of 6029704 shares. The daily chart for MDT points out that the company has recorded 14.91% gains over the past six months. If we look at the
Medtronic Plc [NYSE: MDT] price surged by 0.89 percent to reach at $0.72. The one-year MDT stock forecast points to a potential upside of 13.36. The average equity rating for MDT stock is currently 2.35, trading closer to a bullish pattern in the stock market.
Medtronic Plc [NYSE: MDT] surged by $0.1 during the normal trading session on while it closed the day at $80.23. Medtronic Plc stock has also loss -3.23% of its value over the past 7 days. However, MDT stock has declined by -8.22% in the 3
Medtronic Plc [NYSE: MDT] loss -1.95% or -1.65 points to close at $82.91 with a heavy trading volume of 8706995 shares. The company report on April 8, 2024 at 10:15 AM that New Documentary Released by Medtronic: “A Voice for Health”. Join us on a
Medtronic Plc [NYSE: MDT] loss -2.09% or -1.82 points to close at $85.20 with a heavy trading volume of 6007120 shares. The company report on March 27, 2024 at 4:17 PM that Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business
Medtronic Plc [NYSE: MDT] closed the trading session at $86.92. The company report on March 27, 2024 at 4:17 PM that Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update. Initiated enrollment of the BACKBEAT global pivotal study evaluating AVIM
Medtronic Plc [NYSE: MDT] price surged by 0.54 percent to reach at $0.45. The company report on March 13, 2024 at 8:00 AM that Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting. New pharmacokinetic
Medtronic Plc [NYSE: MDT] price surged by 0.28 percent to reach at $0.24. The company report on March 9, 2024 at 5:40 AM that New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management. New data presented at
Medtronic Plc [NYSE: MDT] stock went on a downward path that fall over -0.54% on Tuesday, amounting to a one-week price increase of more than 0.91%. The company report on March 5, 2024 at 4:30 PM that Medtronic EVP & CFO Karen Parkhill to participate
Medtronic Plc [NYSE: MDT] closed the trading session at $83.67. The company report on February 26, 2024 at 8:00 AM that Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy
© 2024, Powered by Smart TechOne
